Jacobs Levy Equity Management’s Vertex Pharmaceuticals VRTX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $22.7M | Sell |
|
|||||
|
2025
Q1 | $32.1M | Buy |
|
|||||
|
2024
Q1 | – | Sell |
|
|||||
|
2023
Q4 | $41M | Sell |
|
|||||
|
2023
Q3 | $198M | Buy |
|
|||||
|
2023
Q2 | $194M | Sell |
|
|||||
|
2023
Q1 | $196M | Sell |
|
|||||
|
2022
Q4 | $184M | Buy |
|
|||||
|
2022
Q3 | $58.4M | Buy |
|
|||||
|
2022
Q2 | $39.3M | Buy |
|
|||||
|
2022
Q1 | $13.8M | Buy |
|
|||||
|
2021
Q4 | $7.74M | Sell |
|
|||||
|
2021
Q3 | $82.9M | Sell |
|
|||||
|
2021
Q2 | $127M | Buy |
|
|||||
|
2021
Q1 | $3.8M | Sell |
|
|||||
|
2020
Q4 | $31.3M | Buy |
|
|||||
|
2020
Q3 | $9.77M | Sell |
|
|||||
|
2020
Q2 | $15.8M | Buy |
|
|||||
|
2019
Q2 | – | Sell |
|
|||||
|
2019
Q1 | $17M | Sell |
|
|||||
|
2018
Q4 | $53.5M | Buy |
|
|||||
|
2018
Q3 | $49.1M | Buy |
|
|||||
|
2018
Q2 | $38.2M | Buy |
|
|||||
|
2018
Q1 | $33M | Buy |
|
|||||
|
2017
Q4 | $29.5M | Buy |
|
|||||
|
2017
Q3 | $28.1M | Buy |
|
|||||
|
2017
Q2 | $22.7M | Sell |
|
|||||
|
2017
Q1 | $23.6M | Sell |
|
|||||
|
2016
Q4 | $17.7M | Buy |
|
|||||
|
2016
Q3 | $767K | Buy |
|
|||||
|
2014
Q2 | – | Sell |
|
|||||
|
2014
Q1 | $4.87M | Buy |
|